3B Future Health Fund is an investment fund with focus on early-stage investment opportunities in areas of high unmet patient need, mainly oncology and rare disease therapeutics. We focus on start-up companies based in Europe, the US and Israel. We support companies with potential first-in-class assets, revolutionary insights, experienced management teams and a strong investor syndicate. We typically make our initial investment in companies raising Series A rounds, but in some cases even earlier. Our team has over 40 years of experience across the healthcare industry. It includes senior leaders with solid expertise in drug discovery, research and development, drug manufacturing, business development and licensing, as well as investment fund management. We have four General Partners: Riccardo Braglia, Roberto De Ponti, Francesco Granata and Francesco Giavatto; and two Venture Partners Marianne Bjordal and Paolo Paoletti. https://3bfuturehealth.com/